Targeted Cancer Therapies Boost U.S. Approvals to 15-Year High

Targeted Cancer Therapies Boost U.S. Approvals to 15-Year High

Blood smear of the final blast crisis phase of chronic myelogenous lleukemia. Photograph: CDC